# Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

> **NCT07048808** · PHASE2 · RECRUITING · sponsor: **XyloCor Therapeutics, Inc.** · enrollment: 106 (estimated)

## Conditions studied

- Refractory Angina
- Coronary Artery Disease

## Interventions

- **COMBINATION_PRODUCT:** XC001
- **COMBINATION_PRODUCT:** Sham (No Treatment)

## Key facts

- **NCT ID:** NCT07048808
- **Lead sponsor:** XyloCor Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-24
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07048808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07048808, "Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07048808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*